Ahn A, Park S-S, Kim Y, Lee JY, Lee J-M, Jung J, Kim M, Min C-K. Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104). Haematologica 2024;109(12):4100-4105; https://doi.org/10.3324/haematol.2024.285278.